Crediti Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 178.32M 11.98M 2026-09
Alnylam Pharmaceuticals USD 1.08B 172.17M 2026-09
Amarin USD 126.83M 477K 2025-12
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
BioMarin Pharmaceutical USD 1.08B 15.31M 2026-09
DBV Technologies USD 17.5M 2.4M 2026-09
Halozyme Therapeutics USD 518.59M 65.26M 2026-09
Incyte USD 1.24B 111.82M 2026-09
Insmed USD 259.27M 43.94M 2026-09
Ionis Pharmaceuticals USD 88M 29.15M 2026-09
Neurocrine Biosciences USD 957.3M 70.3M 2026-09
PTC Therapeutics USD 239.04M 19.12M 2026-06
Sarepta Therapeutics USD 385.98M 7.82M 2026-09
Ultragenyx Pharmaceutical USD 200M 140M 2026-06
United Therapeutics USD 348.6M 38.3M 2026-09